Meeting
2024 ASCO Quality Care Symposium
Outcomes with initiation of inpatient immunotherapy.
Authors
Jennifer Aline Marks
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
Jennifer Aline Marks , Laura Gosa Barrett , Minhee Kang , Sharon O'Brien , Stephen V. Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care
Sub Track
Cost and Cost-Effectiveness of Care
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 7)
DOI
10.1200/OP.2024.20.10_suppl.7
Abstract #
7
Poster Bd #
A1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.
First Author: Sun Young Jeong
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla
Poster
2023 ASCO Genitourinary Cancers Symposium
US real-world first-line (1L) treatment patterns and outcomes for patients with metastatic urothelial carcinoma (mUC) following maintenance avelumab approval.
First Author: Haojie Li